NSECredit Rating- OthersESG1d ago
Zensar Technologies Limited
Credit Rating- Others
Zensar Technologies Limited has informed the Exchange about the Environmental, Social and Governance (ESG) Score under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The ESG Report was issued by NSE Sustainability Ratings and Analytics Limited, a SEBI-registered ESG Rating Provider, and assigned an overall ESG Rating of 76 under the category 'Leader' based on disclosures pertaining to FY2026.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults6d ago
Zensar Technologies Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Zensar Technologies Limited has informed the Exchange about the schedule of Q2FY27 Results Earnings Conference Call on October 29, 2026, to be represented by CEO and CFO.
NSECopy of Newspaper Publication10 Oct 2026
Zensar Technologies Limited
Copy of Newspaper Publication
Zensar Technologies Limited has informed the Exchange about a special window opened for lodgement of transfer and dematerialization (demat) requests for physical securities sold/purchased prior to April 01, 2019.
NSECertificate under SEBI (Depositories and Participants) Regulations, 20188 Oct 2026
Zensar Technologies Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Zensar Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with Regulation 74(5) for the quarter ended September 30, 2026.
NSEOptions to purchase securitiesBonus/Split7 Oct 2026
Zensar Technologies Limited
Options to purchase securities
Zensar Technologies Limited has informed the Exchange about the allotment of 162,619 fully paid equity shares to employees against the exercise of ESOPs, increasing the issued and subscribed share capital to Rs. 455,486,664.
NSETrading WindowResults30 Sept 2026
Zensar Technologies Limited
Trading Window
Zensar Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to consideration of unaudited financial results for the quarter and half year ended September 30, 2026.
NSECredit Rating- NewRating Change31 Aug 2026
Zensar Technologies Limited
Credit Rating- New
Zensar Technologies Limited has informed the Exchange about ICRA Limited re-affirming the credit rating for Long Term/Short Term-Fund Based/Non-Fund Based as [ICRA]AA+ (Stable)/[ICRA]A1+.
NSEOptions to purchase securitiesBonus/Split24 Aug 2026
Zensar Technologies Limited
Options to purchase securities
Zensar Technologies Limited has informed the Exchange about the allotment of 25,691 fully paid equity shares of Rs. 2/- each to employees against the exercise of ESOPs, increasing the issued and subscribed share capital to Rs. 455,161,426.
NSEGeneral UpdatesM&A14 Aug 2026
Zensar Technologies Limited
General Updates
Zensar Technologies Limited has informed the Exchange about the merger of M3BI LLC with Zensar Technologies Inc. All requisite filings for the merger were completed with local authorities on August 13, 2026, and the merger will become effective from September 1, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates10 Aug 2026
Zensar Technologies Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Zensar Technologies Limited has informed the Exchange about the schedule of analyst/institutional investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates10 Aug 2026
Zensar Technologies Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Zensar Technologies Limited has informed the Exchange about the schedule of analyst/institutional investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
NSECredit RatingESG8 Aug 2026
Zensar Technologies Limited
Credit Rating
Zensar Technologies Limited has been assigned an ESG Score of 74 by Crisil for the fiscal year 2026, reflecting the company's performance on ESG parameters.
NSECopy of Newspaper Publication8 Aug 2026
Zensar Technologies Limited
Copy of Newspaper Publication
Zensar Technologies Limited has informed the Exchange about a special window opened for lodgement of transfer and dematerialization (demat) requests for physical securities sold/purchased prior to April 1, 2019.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults5 Aug 2026
Zensar Technologies Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Zensar Technologies Limited has made available the transcript of its earnings call held on July 30, 2026, discussing its financial results for the quarter ended June 30, 2026.
NSEShareholders meetingResults31 Jul 2026
Zensar Technologies Limited
Shareholders meeting
Zensar Technologies Limited has submitted the Exchange a copy Scrutinizer's report of the Annual General Meeting held on July 30, 2026, and informed the Exchange regarding voting results. All resolutions were passed at the AGM with requisite majority.
NSECopy of Newspaper PublicationResults31 Jul 2026
Zensar Technologies Limited
Copy of Newspaper Publication
Zensar Technologies Limited has informed the Exchange about the publication of unaudited financial results for the quarter ended June 30, 2026, in newspapers Financial Express and Loksatta, as approved by the Board on July 29, 2026.
NSEGeneral UpdatesM&A31 Jul 2026
Zensar Technologies Limited
General Updates
Zensar Technologies Limited has informed the Exchange about the update on merger of US Subsidiary. The merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc. has been completed with the relevant local authorities/state agencies on July 30, 2026, and the merger shall become effective from August 1, 2026.
NSEShareholders meetingResults30 Jul 2026
Zensar Technologies Limited
Shareholders meeting
Zensar Technologies Limited held its 63rd Annual General Meeting on July 30, 2026, through video conferencing. The meeting was attended by 42 members, and the company's financial statements for the year ended March 31, 2026, were approved. The company also declared an interim dividend and re-appointed H. V. Goenka as a director.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults30 Jul 2026
Zensar Technologies Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Zensar Technologies Limited has made available the audio recording of its Q1FY27 earnings call on its website, under the Investors Corner section.
NSEGeneral UpdatesM&A29 Jul 2026
Zensar Technologies Limited
General Updates
Zensar Technologies Limited has received in-principle approval for the merger of its US-based step-down subsidiaries, Bridgeview Life Sciences LLC and M3BI LLC, into its material wholly owned subsidiary, Zensar Technologies Inc., USA. The merger aims to achieve greater business synergies and operational efficiencies.